Presentation Information
[3P-0764]Chagas Disease Drug Discovery: An Integrated Pipeline for Anti-Trypanosoma cruzi Hit Prioritization Incorporating Transcriptomic Profiling
○Michele Lika Furuya1,2, Japheth Kibet Ng’etich2,3,4,5, Mizuki Hayashishita1,6, Mohammed Suliman Omer Tagod2, Naoya Kadofusa7, Ayato Sato7,8, Jean-Robert Ioset9, Lucas Silva Franco9, Luiza Cruz9, Takeshi Nara10, Takaya Sakura1,2,11, Daniel Ken Inaoka1,2,11,12 (1.TMGH, Nagasaki Univ., 2.Dep. of Inf. Bioch., NEKKEN, Nagasaki Univ., 3.Dep. of Mol. Microb. and Imm. Grad. Sch. of Biomed. Sci., Nagasaki Univ., 4.Prog. for Nurturing Global Leaders in Trop. and Emerg. Comm. Dis., Grad. Sch. of Biomed. Sci., Nagasaki Univ., 5.Ctr. for Trad. Med. and Drug Res., Kenya Med. Res. Inst., Kenya, 6.Brazil Res. Sta., Natl. Res. Ctr. for the Ctrl. and Prev. of Inf. Dis. (CCPID), Nagasaki Univ., 7.Inst. of Transformative Bio-Mol (WPI-ITbM), Nagoya Univ., 8.Ctr. for One Med Innov. Trans. Res. (COMIT), Nagoya Univ., 9.Drugs for Neglected Diseases Initiative (DNDi), 10.Lab. of Mol. Parasitology, Grad. Sch. of Life Sci. and Tech., Iryo Sosei Univ., 11.Dep. of Mol. Inf. Dyn., NEKKEN, Nagasaki Univ., 12.Dep. of Biomed. Chem., Grad. Sch. of Med., The Univ.of Tokyo)
Password required to view
Password required to view or download.
Check your name badge for the password.
Check your name badge for the password.
Comment
To browse or post comments, you must log in.Log in
